(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.
To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Bibikova MV and Bondareva NS | [Drugs of microbial origin for treatment of atherosclerosis]. | 1998 | Antibiot. Khimioter. | pmid:9777104 |
Michikawa M and Yanagisawa K | Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis. | 1998 | J. Neurosci. Res. | pmid:9778150 |
Saenz MT et al. | Cytostatic activity of some compounds from the unsaponifiable fraction obtained from virgin olive oil. | 1998 | Farmaco | pmid:9786644 |
Schedin S et al. | Alterations in the biosynthesis of cholesterol, dolichol and dolichyl-P in the genetic cholesterol homeostasis disorder, Niemann-Pick type C disease. | 1998 | Biochim. Biophys. Acta | pmid:9795206 |
Singh M et al. | A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2. | 1998 | Vaccine | pmid:9795387 |
Cattel L and Ceruti M | Inhibitors of 2,3-oxidosqualene cyclase as tools for studying the mechanism and function of the enzyme. | 1998 | Crit. Rev. Biochem. Mol. Biol. | pmid:9827705 |
Smiałek M et al. | Experimental squalene encephaloneuropathy in the rat. | 1997 | Folia Neuropathol | pmid:9833408 |
Goldberg I and Shechter I | Occurrence of squalene in methanol-grown bacteria. | 1978 | J. Bacteriol. | pmid:98521 |
Fisher JE et al. | Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9874784 |
Fernández JJ et al. | Evaluation of the cytotoxic activity of polyethers isolated from Laurencia. | 1998 | Bioorg. Med. Chem. | pmid:9925286 |
Bell FP | Inhibition of hepatic sterol and squalene biosynthesis in rats fed di-i-ethylhexyl phthalate. | 1976 | Lipids | pmid:994746 |
Johnson RC and Shah SN | Binding of squalene, lanosterol, desmosterol, and cholesterol to proteins in brain and liver 105,000 g supernatant fractions: evidence for specific binding sites. | 1976 | Lipids | pmid:994754 |
Novoselova EG and KolomiÄtseva IK | [Early radiation impairments of the metabolism of cholesterol, squalene and ubiquinone in rat liver]. | 1976 Jul-Aug | Radiobiologiia | pmid:996254 |
Minutello M et al. | Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. | 1999 | Vaccine | pmid:9987141 |
Hilgers LA et al. | Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant. | 1999 | Vaccine | pmid:9987157 |
Kelly GS | Squalene and its potential clinical uses. | 1999 | Altern Med Rev | pmid:9988781 |